Mesoblast pain drug agreement downgraded by German partner

MELBOURNE: Mesoblast and its German pharmaceutical partner Grünenthal have downgraded their collaboration agreement ... read more
Imugene shares soar on US breast cancer trial

MELBOURNE: Cancer vaccine making biotech Imugene opened 8.6 per cent higher this morning ... read more